BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19570104)

  • 1. Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid.
    Tang TH; Fitzsimmons TR; Bartold PM
    J Clin Periodontol; 2009 Sep; 36(9):713-8. PubMed ID: 19570104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
    Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
    J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
    Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
    J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin levels in peri-implant crevicular fluid.
    Arikan F; Buduneli N; Kütükçüler N
    Clin Oral Implants Res; 2008 Mar; 19(3):283-8. PubMed ID: 18081868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment.
    Buduneli N; Buduneli E; Kütükçüler N
    J Periodontol; 2009 Aug; 80(8):1274-80. PubMed ID: 19656027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients.
    Lappin DF; Sherrabeh S; Jenkins WM; Macpherson LM
    J Clin Periodontol; 2007 Apr; 34(4):271-7. PubMed ID: 17378883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study.
    Arikan F; Buduneli N; Lappin DF
    Int J Oral Maxillofac Implants; 2011; 26(2):282-9. PubMed ID: 21483881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.
    Gümüş P; Buduneli E; Bıyıkoğlu B; Aksu K; Saraç F; Nile C; Lappin D; Buduneli N
    J Periodontol; 2013 Nov; 84(11):1627-37. PubMed ID: 23327689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Receptor Activator of Nuclear Factor Ligand and Osteoprotegerin Levels in Gingival Crevicular Fluid among Cigarette Smokers and Non-smokers with and without Periodontitis.
    Abduljalil SMA; Hashim NT; Rahman MM; Chaitanya NC; Mukhtar MM; Gismalla BG
    J Contemp Dent Pract; 2023 Oct; 24(10):771-778. PubMed ID: 38152910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients.
    Buduneli N; Biyikoğlu B; Sherrabeh S; Lappin DF
    J Clin Periodontol; 2008 Oct; 35(10):846-52. PubMed ID: 18727653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
    Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble RANKL in crevicular fluid of dental implants: a pilot study.
    Monov G; Strbac GD; Baron M; Kandler B; Watzek G; Gruber R
    Clin Implant Dent Relat Res; 2006; 8(3):135-41. PubMed ID: 16919021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study.
    Rakic M; Lekovic V; Nikolic-Jakoba N; Vojvodic D; Petkovic-Curcin A; Sanz M
    Clin Oral Implants Res; 2013 Oct; 24(10):1110-6. PubMed ID: 22708989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
    César-Neto JB; Duarte PM; de Oliveira MC; Tambeli CH; Sallum EA; Nociti FH
    J Periodontal Res; 2007 Apr; 42(2):184-91. PubMed ID: 17305878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis.
    Ishii R; Morimoto A; Ikushima S; Sugimoto T; Asami K; Bessho F; Kudo K; Tsunematu Y; Fujimoto J; Imashuku S
    Pediatr Blood Cancer; 2006 Aug; 47(2):194-9. PubMed ID: 16358318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status.
    Tobón-Arroyave SI; Isaza-Guzmán DM; Restrepo-Cadavid EM; Zapata-Molina SM; Martínez-Pabón MC
    J Clin Periodontol; 2012 Dec; 39(12):1132-40. PubMed ID: 23039038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of periodontal treatment on receptor activator of NF-κB ligand and osteoprotegerin levels and relative ratio in gingival crevicular fluid.
    Bostanci N; Saygan B; Emingil G; Atilla G; Belibasakis GN
    J Clin Periodontol; 2011 May; 38(5):428-33. PubMed ID: 21261673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
    Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
    J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.